Updated: 1/15/21. The results chart includes audits where the findings have been finalized. Remaining audits are still under review. Information on Corrective Action Plans and Sanctions will be updated once approved by HRSA. HRSA recommends covered entities do not contact audited manufacturers regarding sanctions until a corrective action plan has been approved by HRSA and posted on this website.
Results posted for 5 audits.
| Manufacturer | Labeler Codes Reviewed | State | OPA Findings | Sanction | Corrective Action Status | Manufacturer Contact Information |
|---|---|---|---|---|---|---|
| Indivior Incorporated | 12496 | VA | No adverse findings | None |
N/A |
|
| Kyowa Kirin, Inc. | 42747 | NJ | No adverse findings | None | N/A | |
| Eisai, Inc. | 62856 | NJ | No adverse findings | None | N/A | |
| Westminster Pharmaceuticals, LLC | 69367 | TN |
|
Repayment to covered entities |
CAP approved |
Contract Specialist 1-888-354-9939 ext. 1019 |
| Pharmaceutical Associates, Inc. | 00121, 00486 |
SC |
|
Repayment to covered entities | CAP approved | Labeler 00121: Chargeback Systems Manager patfowler@paipharma.com 864-277-7282 x3382 Labeler 00486: |
